| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Mar 4, 2025 | Mar 6, 2025 | Adaptive Biotechnologies Corp | Chief Commercial Officer, MRD | Sell | 95.0 | +93,948 | 37.09% | ✗ | $181.6K |
| Mar 4, 2024 | Mar 6, 2024 | Adaptive Biotechnologies Corp | Chief Commercial Officer, MRD | Sell | 91.3 | +119,988 | 93.52% | ✗ | $44.6K |
| Dec 10, 2020 | Dec 11, 2020 | Adaptive Biotechnologies Corp | SVP, Diagnostics, clonoSEQ | Sell | 5.0 | -25,000 | -100.00% | ✓ | $1.4M |
| Sep 29, 2020 | Oct 1, 2020 | Adaptive Biotechnologies Corp | SVP, Diagnostics, clonoSEQ | Sell | 7.5 | -10,000 | -100.00% | ✓ | $500K |